TABLE 3.

SOD, GSH-Px activities, and MDA levels in liver homogenates after geniposide treatment.

Group	SOD (U/mg prot)	GSH-Px (U/mg prot)	MDA (nmol/mg prot)
Control	30.44 ± 3.29	265.76 ± 36.78	2.44 ± 0.64
Model	23.90 ± 1.24##	139.41 ± 45.49##	4.55 ± 1.26##
Geniposide	29.15 ± 4.75**	225.29 ± 43.09**	2.76 ± 0.47**

Control, model, and geniposide groups (n = 10 per group). Data are presented as mean ± SD. #p < 0.05 and ^## p < 0.01, Model group vs. Control group; ^∗ p < 0.05, Geniposide group vs. Model group.